Compare ATAI & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAI | NOTE |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | 439 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 15.9M |
| IPO Year | 2021 | N/A |
| Metric | ATAI | NOTE |
|---|---|---|
| Price | $3.55 | $0.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $15.57 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 4.7M | 298.3K |
| Earning Date | 03-06-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,000.00 | N/A |
| Revenue This Year | N/A | $2.85 |
| Revenue Next Year | N/A | $3.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $0.40 |
| 52 Week High | $6.73 | $5.59 |
| Indicator | ATAI | NOTE |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 22.39 |
| Support Level | $3.48 | $0.47 |
| Resistance Level | $4.30 | $0.67 |
| Average True Range (ATR) | 0.22 | 0.10 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 28.93 | 8.72 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.